Search Results - "MESH: Epidemiologic Methods"

Cares: an interactive tool for case-crossover analyses of electronic medical records for patient safety

Authors: Caron, Alexandre Chazard, Emmanuel Muller, Joris et al.

Contributors: Caron, Alexandre Chazard, Emmanuel Muller, Joris et al.

Subject Terms: clinical epidemiology, adverse event, Patient safety, data analytics, medical informatics, big data, Mesh:Risk, Mesh:Epidemiologic Methods, Mesh:Electronic Health Records, Mesh:Databases, Mesh:Factual, Mesh:Cross-Over Studies, Mesh:Patient Safety, Mesh:Hemorrhage/etiology, Mesh:Thromboembolism/etiology, Mesh:Humans, Mesh:Software

File Description: application/octet-stream; application/rdf+xml; charset=utf-8; application/pdf

Relation: Journal of the American Medical Informatics Association . JAMIA; J. Am. Med. Inf. Assoc.; http://hdl.handle.net/20.500.12210/17178

Availability: https://hdl.handle.net/20.500.12210/17178

Méthodologie des études neuroépidémiologiques dans les pays tropicaux : un challenge ?

Authors: Preux, Pierre-Marie Ratsimbazafy, Voa Bhalla, Devender et al.

Contributors: Preux, Pierre-Marie Ratsimbazafy, Voa Bhalla, Devender et al.

Source: Revue Neurologique. 168:211-215

Subject Terms: MESH: Humans, Data Collection, 1. No poverty, MESH: Epidemiologic Methods, MESH: Nervous System Diseases, MESH: Tropical Medicine, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Tropical Medicine, Humans, MESH: Data Collection, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Nervous System Diseases, Epidemiologic Methods, MESH: Developing Countries, Developing Countries

Access URL: https://pubmed.ncbi.nlm.nih.gov/22305544
https://www.sciencedirect.com/science/article/pii/S0035378711004553
https://pubmed.ncbi.nlm.nih.gov/22305544/
https://europepmc.org/article/MED/22305544
https://hal-unilim.archives-ouvertes.fr/hal-00920792
https://www.ncbi.nlm.nih.gov/pubmed/22305544

HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis

Authors: Chung, Ho Yin Machado, Pedro van Der Heijde, Désirée et al.

Contributors: Chung, Ho Yin Machado, Pedro van Der Heijde, Désirée et al.

Source: Annals of the Rheumatic Diseases. 70:1930-1936

Subject Terms: Adult, Male, Delayed Diagnosis, MESH: Age of Onset, MESH: Spondylarthritis, [SDV]Life Sciences [q-bio], MESH: Phenotype, MESH: Epidemiologic Methods, Severity of Illness Index, MESH: Prognosis, MESH: Magnetic Resonance Imaging, Young Adult, 03 medical and health sciences, 0302 clinical medicine, MESH: Severity of Illness Index, Spondylarthritis, Humans, Sacroiliitis, Age of Onset, MESH: Sacroiliac Joint, MESH: Sacroiliitis, Axis, Cervical Vertebra, HLA-B27 Antigen, MESH: Middle Aged, MESH: Humans, MESH: Biological Markers, MESH: Adult, Sacroiliac Joint, Middle Aged, Prognosis, Magnetic Resonance Imaging, MESH: Male, 3. Good health, MESH: Delayed Diagnosis, Phenotype, MESH: Young Adult, Back Pain, MESH: Back Pain, Female, MESH: HLA-B27 Antigen, Epidemiologic Methods, MESH: Female, Biomarkers, MESH: Axis

Access URL: https://pubmed.ncbi.nlm.nih.gov/21803752
http://discovery.ucl.ac.uk/1437887/
http://www.lacohortedesir.fr/wp-content/uploads/2011/06/HLA-B27-in-early-axial-SpA.pdf
https://europepmc.org/article/MED/21803752
https://www.narcis.nl/publication/RecordID/oai%3Ascholarlypublications.universiteitleiden.nl%3Aitem_3013989
https://ard.bmj.com/content/70/11/1930
https://publicatt.unicatt.it/handle/10807/169326
https://hdl.handle.net/1887/108793
https://hdl.handle.net/1887/118770
https://hdl.handle.net/10807/169326
https://doi.org/10.1136/ard.2011.152975
http://hdl.handle.net/10722/249052

Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis

Authors: Mouterde, G. Lukas, C. Logeart, I. et al.

Contributors: Mouterde, G. Lukas, C. Logeart, I. et al.

Source: Annals of the Rheumatic Diseases. 70:1251-1256

Subject Terms: Adult, Male, MESH: Rheumatoid Factor, MESH: Synovitis, [SDV]Life Sciences [q-bio], MESH: Arthritis, Blood Sedimentation, MESH: Epidemiologic Methods, Peptides, Cyclic, MESH: Prognosis, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, MESH: Early Diagnosis, Rheumatoid Factor, Rheumatoid, MESH: Autoantibodies, Humans, MESH: Blood Sedimentation, MESH: HLA-DRB1 Chains, Aged, Autoantibodies, MESH: Aged, Cyclic, MESH: Humans, MESH: Middle Aged, MESH: Peptides, Arthritis, MESH: Biological Markers, MESH: Adult, HLA-DR Antigens, Middle Aged, MESH: HLA-DR Antigens, Prognosis, MESH: Male, 3. Good health, Radiography, Early Diagnosis, MESH: Young Adult, Disease Progression, MESH: Disease Progression, Female, Epidemiologic Methods, MESH: Female, MESH: Seasons, Biomarkers, HLA-DRB1 Chains

Access URL: https://pubmed.ncbi.nlm.nih.gov/21515603
https://ard.bmj.com/lookup/doi/10.1136/ard.2010.144402
https://www.ncbi.nlm.nih.gov/pubmed/21515603
https://ard.bmj.com/content/70/7/1251.abstract
https://ard.bmj.com/content/annrheumdis/70/7/1251.full.pdf
https://ard.bmj.com/content/70/7/1251

Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study

Authors: Grégoire Le Gal Aurélien Delluc Emmanuelle Le Moigne et al.

Contributors: Grégoire Le Gal Aurélien Delluc Emmanuelle Le Moigne et al.

Source: British Journal of Haematology. 154:486-491

Subject Terms: MESH: Pulmonary Embolism, Adult, Male, MESH: Mutation, Adolescent, MESH: Factor V, MESH: Epidemiologic Methods, MESH: Venous Thromboembolism, MESH: Body Mass Index, Body Mass Index, Young Adult, 03 medical and health sciences, 0302 clinical medicine, 80 and over, MESH: Obesity, Humans, Genetic Predisposition to Disease, Obesity, MESH: Prothrombin, Aged, MESH: Adolescent, MESH: Aged, Aged, 80 and over, 2. Zero hunger, MESH: Humans, MESH: Middle Aged, MESH: Genetic Predisposition to Disease, Factor V, MESH: Adult, Venous Thromboembolism, Middle Aged, MESH: Male, 3. Good health, MESH: France, MESH: Young Adult, Mutation, Female, Prothrombin, France, Epidemiologic Methods, Pulmonary Embolism, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2011.08592.x
https://pubmed.ncbi.nlm.nih.gov/21671893
https://europepmc.org/article/MED/21671893
http://www.ncbi.nlm.nih.gov/pubmed/21671893
https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2011.08592.x

The epidemiology of cough

Authors: Kauffmann, Francine Varraso, Raphaëlle Nadif, Rachel et al.

Contributors: Kauffmann, Francine Varraso, Raphaëlle Nadif, Rachel et al.

Source: Pulmonary Pharmacology & Therapeutics. 24:289-294

Subject Terms: Male, MESH: Asthma, MESH: Epidemiologic Methods, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, MESH: Sex Factors, cough, Surveys and Questionnaires, MESH: Cough, gender, Humans, genetics, MESH: Circadian Rhythm, MESH: Age Factors, MESH: Humans, MESH: Questionnaires, MESH: Chronic Disease, Age Factors, MESH: Male, Asthma, Circadian Rhythm, 3. Good health, MESH: France, Europe, Cough, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Chronic Disease, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, epidemiology, Female, MESH: Europe, France, Epidemiologic Methods, MESH: Female, environment

File Description: application/pdf

Access URL: https://www.hal.inserm.fr/inserm-00744419/file/kauffmann_ppt_2010_sp.pdf
https://pubmed.ncbi.nlm.nih.gov/21044889
http://www.ncbi.nlm.nih.gov/pubmed/21044889
https://www.hal.inserm.fr/inserm-00744419
http://www.sciencedirect.com/science/article/pii/S1094553910001264
https://pubmed.ncbi.nlm.nih.gov/21044889/
https://www.sciencedirect.com/science/article/pii/S1094553910001264
https://europepmc.org/article/MED/21044889

Return home at the end of life: Patients’ vulnerability and risk factors

Authors: Vassal, Pascale Le Coz, Pierre Hervé, Christian et al.

Contributors: Vassal, Pascale Le Coz, Pierre Hervé, Christian et al.

Source: Palliative Medicine. 25:139-147

Subject Terms: Male, MESH: Delivery of Health Care, MESH: Epidemiologic Methods, 0302 clinical medicine, MESH: Risk Factors, Residence Characteristics, Risk Factors, 80 and over, MESH: Residence Characteristics, MESH: Terminally Ill, MESH: Patient Preference, MESH: Aged, Aged, 80 and over, Terminal Care, MESH: Middle Aged, Palliative Care, Patient Preference, MESH: Caregivers, Middle Aged, Home Care Services, 3. Good health, MESH: Terminal Care, Caregivers, MESH: Palliative Care, Female, France, 0305 other medical science, Adult, Attitude to Death, Adolescent, MESH: Home Care Services, 03 medical and health sciences, MESH: Attitude to Death, Humans, Family, MESH: Family, Aged, MESH: Adolescent, MESH: Humans, MESH: Adult, [SDV.ETH] Life Sciences [q-bio]/Ethics, MESH: Male, MESH: Vulnerable Populations, [SDV.ETH]Life Sciences [q-bio]/Ethics, MESH: France, Epidemiologic Methods, MESH: Female, Delivery of Health Care

Access URL: https://pubmed.ncbi.nlm.nih.gov/21248182
http://journals.sagepub.com/doi/10.1177/0269216310385876
http://journals.sagepub.com/doi/pdf/10.1177/0269216310385876
https://www.ncbi.nlm.nih.gov/pubmed/21248182
https://www.hal.inserm.fr/inserm-00612231
https://journals.sagepub.com/doi/10.1177/0269216310385876
https://inserm.hal.science/inserm-00612231v1
https://doi.org/10.1177/0269216310385876

Prognostic value of the Geneva prediction rule in patients in whom pulmonary embolism is ruled out: Outcomes after PE is ruled out

Authors: Bertoletti, Laurent Le Gal, Grégoire Aujesky, D. et al.

Contributors: Bertoletti, Laurent Le Gal, Grégoire Aujesky, D. et al.

Source: Journal of Internal Medicine, Vol. 269, No 4 (2011) pp. 433-40

Subject Terms: MESH: Pulmonary Embolism, Male, MESH: Epidemiologic Methods, France/epidemiology, Switzerland/epidemiology, 0302 clinical medicine, MESH: Belgium, Belgium, Neoplasms, MESH: Neoplasms, Cardiovascular Diseases/mortality, MESH: Aged, ddc:616, 2. Zero hunger, MESH: Middle Aged, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Middle Aged, Prognosis, 3. Good health, Cardiovascular Diseases, Female, Neoplasms/mortality, France, Respiratory Insufficiency, Switzerland, Adult, Respiratory Insufficiency/mortality, MESH: Switzerland, Patient Readmission, MESH: Prognosis, Decision Support Techniques, 03 medical and health sciences, MESH: Patient Readmission, Humans, Pulmonary Embolism/diagnosis, Belgium/epidemiology, Aged, MESH: Humans, MESH: Cardiovascular Diseases, MESH: Decision Support Techniques, MESH: Adult, MESH: Male, MESH: France, Patient Readmission/statistics & numerical data, Epidemiologic Methods, Pulmonary Embolism, MESH: Female, MESH: Respiratory Insufficiency, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/21198991
http://okina.univ-angers.fr/publications/ua6465
https://dial.uclouvain.be/pr/boreal/en/object/boreal%3A104381
https://archive-ouverte.unige.ch/unige:23978
https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2010.02328.x
https://www.ncbi.nlm.nih.gov/pubmed/21198991
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2796.2010.02328.x
https://archive-ouverte.unige.ch/unige:23978

Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM‐TC)

Authors: Robin, Marie Tabrizi, Reza Mohty, Mohamad et al.

Contributors: Robin, Marie Tabrizi, Reza Mohty, Mohamad et al.

Source: British Journal of Haematology. 152:331-339

Subject Terms: Adult, Male, Transplantation Conditioning, MESH: Graft Survival, MESH: Graft vs Host Disease, Graft vs Host Disease, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Splenectomy, MESH: Epidemiologic Methods, MESH: Prognosis, Young Adult, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Recurrence, Humans, MESH: Hematopoietic Stem Cell Transplantation, MESH: Transplantation Conditioning, MESH: Treatment Outcome, Aged, MESH: Aged, MESH: Middle Aged, MESH: Humans, Graft Survival, Hematopoietic Stem Cell Transplantation, MESH: Adult, Middle Aged, Prognosis, MESH: Male, MESH: Recurrence, MESH: Histocompatibility, 3. Good health, Treatment Outcome, MESH: Young Adult, Primary Myelofibrosis, Histocompatibility, Splenectomy, Female, MESH: Primary Myelofibrosis, Epidemiologic Methods, MESH: Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/21133885
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2010.08417.x
https://europepmc.org/article/MED/21133885
http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2010.08417.x/suppinfo
https://pubmed.ncbi.nlm.nih.gov/21133885/
https://www.ncbi.nlm.nih.gov/pubmed/21133885
https://hal-univ-tlse3.archives-ouvertes.fr/hal-00849650v1

Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial

Authors: Monnien, Franck Zaki, Harouna Borg, Christophe et al.

Contributors: Monnien, Franck Zaki, Harouna Borg, Christophe et al.

Source: Journal of Clinical Pathology. 63:873-878

Subject Terms: MESH: Neoplasm Proteins, MESH: Cell Nucleus, Adult, Male, STAT3 Transcription Factor, 0301 basic medicine, MESH: Combined Modality Therapy, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Epidemiologic Methods, MESH: Prognosis, 03 medical and health sciences, MESH: Tumor Markers, 0302 clinical medicine, 80 and over, Biomarkers, Tumor, MESH: Chemotherapy, Humans, Phosphorylation, Adjuvant, MESH: Treatment Outcome, Aged, MESH: Aged, Aged, 80 and over, Cell Nucleus, MESH: Middle Aged, MESH: Humans, MESH: Phosphorylation, Rectal Neoplasms, MESH: Rectal Neoplasms, MESH: STAT3 Transcription Factor, MESH: Adult, Middle Aged, Biological, Prognosis, Combined Modality Therapy, MESH: Male, Neoplasm Proteins, 3. Good health, MESH: France, Treatment Outcome, Chemotherapy, Adjuvant, Female, France, Epidemiologic Methods, MESH: Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/20876317
https://jcp.bmj.com/content/63/10/873
http://www.ncbi.nlm.nih.gov/pubmed/20876317
https://jcp.bmj.com/lookup/doi/10.1136/jcp.2010.076414
https://jcp.bmj.com/content/jclinpath/63/10/873.full.pdf
https://jcp.bmj.com/content/63/10/873.share
https://pubmed.ncbi.nlm.nih.gov/20876317/

Validation of the Use of Historical Events to Estimate the Age of Subjects Aged 65 Years and Over in Cotonou (Benin)

Authors: Paraïso, Moussiliou Noël Houinato, Dismand Stephan Guerchet, Maëlenn et al.

Contributors: Paraïso, Moussiliou Noël Houinato, Dismand Stephan Guerchet, Maëlenn et al.

Source: Neuroepidemiology. 35:12-16

Subject Terms: MESH: Aged, Aged, 80 and over, Male, History, MESH: Humans, 4. Education, History, 20th Century, MESH: Epidemiologic Methods, MESH: History, MESH: Male, 20th Century, 03 medical and health sciences, MESH: Benin, MESH: Cross-Sectional Studies, Cross-Sectional Studies, 0302 clinical medicine, 80 and over, Benin, Humans, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Epidemiologic Methods, MESH: Female, Aged

Access URL: https://www.karger.com/Article/Pdf/301715
https://pubmed.ncbi.nlm.nih.gov/20339306
https://core.ac.uk/display/29933873
https://www.karger.com/Article/Pdf/301715
https://hal-unilim.archives-ouvertes.fr/hal-00607346
https://europepmc.org/abstract/MED/20339306

Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort

Authors: Fautrel, Bruno Benhamou, Mathilde Foltz, Violaine et al.

Contributors: Fautrel, Bruno Benhamou, Mathilde Foltz, Violaine et al.

Source: Rheumatology. 49:147-155

Subject Terms: Adult, Male, Time Factors, Adolescent, MESH: Arthritis, MESH: Epidemiologic Methods, Arthritis, Rheumatoid, MESH: Referral and Consultation, Young Adult, 03 medical and health sciences, 0302 clinical medicine, MESH: Practice Guidelines as Topic, MESH: Early Diagnosis, Rheumatoid, Humans, MESH: Quality of Health Care, 10. No inequality, MESH: Family Practice, Referral and Consultation, Aged, Quality of Health Care, MESH: Adolescent, MESH: Aged, MESH: Humans, MESH: Middle Aged, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, MESH: Time Factors, MESH: Adult, Middle Aged, MESH: Male, 3. Good health, MESH: France, Early Diagnosis, MESH: Young Adult, MESH: Guideline Adherence, Practice Guidelines as Topic, Female, MESH: Clinical Competence, Clinical Competence, France, Guideline Adherence, Health Services Research, Epidemiologic Methods, Family Practice, MESH: Female, MESH: Health Services Research, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Access URL: https://academic.oup.com/rheumatology/article-pdf/49/1/147/10653567/kep340.pdf
https://pubmed.ncbi.nlm.nih.gov/19933784
https://www.ncbi.nlm.nih.gov/pubmed/19933784
https://academic.oup.com/rheumatology/article/49/1/147/1790007
http://academic.oup.com/rheumatology/article-abstract/49/1/147/1790007
https://hal.univ-brest.fr/hal-00790224v1
https://doi.org/10.1093/rheumatology/kep340

Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer

Authors: Pivot, Xavier, B. Li, Rubi, K. Thomas, Eva, S. et al.

Contributors: Pivot, Xavier, B. Li, Rubi, K. Thomas, Eva, S. et al.

Source: European Journal of Cancer. 45:2940-2946

Subject Terms: Antineoplastic Agents/administration & dosage, Lung Neoplasms, Antimetabolites, Drug Resistance, Fluorouracil/adverse effects, MESH: Epidemiologic Methods, Deoxycytidine, Deoxycytidine/analogs & derivatives, Breast cancer, 0302 clinical medicine, MESH: Liver Neoplasms, Antineoplastic/administration & dosage, Receptors, Antineoplastic Combined Chemotherapy Protocols, MESH: Receptors, Progesterone, MESH: Treatment Outcome, Fluorouracil/analogs & derivatives, Liver Neoplasms, Progesterone/analysis, Epothilones/adverse effects, Epothilone, Antineoplastic, 3. Good health, ErbB Receptors, MESH: Antineoplastic Combined Chemotherapy Protocols, Fluorouracil/administration & dosage, Treatment Outcome, Epothilones/administration & dosage, Receptors, Estrogen, Liver Neoplasms/secondary, Estrogen/analysis, MESH: Antimetabolites, Breast Neoplasms/drug therapy, MESH: Drug Resistance, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Fluorouracil, Epidermal Growth Factor/analysis, Receptors, Progesterone, Receptor, Antimetabolites, Antineoplastic, [SDV.IMM] Life Sciences [q-bio]/Immunology, Oestrogen receptor-negative, Antineoplastic Agents, Breast Neoplasms, Antineoplastic/adverse effects, Liver Neoplasms/drug therapy, Taxanes, 03 medical and health sciences, MESH: Tumor Markers, Ixabepilone, Biomarkers, Tumor, Humans, MESH: Epothilones, Lung Neoplasms/secondary, Lung Neoplasms/drug therapy, Deoxycytidine/administration & dosage, ER/PR/HER2-negative, Capecitabine, MESH: Humans, Epidermal Growth Factor, Tumor/analysis, Deoxycytidine/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, MESH: Receptor, MESH: Deoxycytidine, Antineoplastic Agents/adverse effects, Biological, Estrogen, MESH: Lung Neoplasms, Breast Neoplasms/chemistry, Drug Resistance, Neoplasm, Epothilones, Triple-negative, MESH: Antineoplastic Agents, Neoplasm, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Epidemiologic Methods, MESH: Female, MESH: Fluorouracil, MESH: Breast Neoplasms, Biomarkers

File Description: 2940~2946

Access URL: https://pubmed.ncbi.nlm.nih.gov/19683429
https://www.sciencedirect.com/science/article/pii/S0959804909005814
https://yonsei.pure.elsevier.com/en/publications/activity-of-ixabepilone-in-oestrogen-receptor-negative-and-oestro
https://www.hal.inserm.fr/inserm-00484423
https://mdanderson.elsevierpure.com/en/publications/activity-of-ixabepilone-in-oestrogen-receptor-negative-and-oestro
https://inserm.hal.science/inserm-00484423v1
https://doi.org/10.1016/j.ejca.2009.07.015

The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis

Authors: De Angelis, Roberta Francisci, Silvia Baili, Paolo et al.

Contributors: De Angelis, Roberta Francisci, Silvia Baili, Paolo et al.

Source: European Journal of Cancer. 45:909-930

Subject Terms: Quality Control, MESH: Humans, MESH: Quality Control, Europe, Neoplasms, Population registries, Survival analysis, Vital statistics, Databases as Topic, Epidemiologic Methods, Humans, Oncology, Cancer Research, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Epidemiologic Methods, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, MESH: Neoplasms, MESH: Europe, cancer survival, MESH: Databases as Topic

Access URL: https://pubmed.ncbi.nlm.nih.gov/19128955
https://www.ncbi.nlm.nih.gov/pubmed/19128955
https://europepmc.org/article/MED/19128955
https://www.sciencedirect.com/science/article/pii/S0959804908009088
https://hal.archives-ouvertes.fr/hal-00492506
https://pubmed.ncbi.nlm.nih.gov/19128955/
https://moh-it.pure.elsevier.com/en/publications/the-eurocare-4-database-on-cancer-survival-in-europe-data-standar
https://hdl.handle.net/11391/102566

Survival of European children and young adults with cancer diagnosed 1995–2002

Authors: Gatta, Gemma Zigon, Giulia Capocaccia, Riccardo et al.

Contributors: Gatta, Gemma Zigon, Giulia Capocaccia, Riccardo et al.

Source: European Journal of Cancer. 45:992-1005

Subject Terms: MESH: Rare Diseases, Male, Adolescent, [SDV.CAN]Life Sciences [q-bio]/Cancer, EMC NIHES-02-65-02, MESH: Epidemiologic Methods, Young Adult, 03 medical and health sciences, Rare Diseases, 0302 clinical medicine, SDG 3 - Good Health and Well-being, MESH: Child, Neoplasms, Humans, MESH: Neoplasms, Preschool, Child, Adolescents, Cancer survival, Children, Europe, Population-based cancer registries, Rare tumours, Young adults, Child, Preschool, Epidemiologic Methods, Female, Infant, Oncology, Cancer Research, Children & young adults, MESH: Adolescent, MESH: Humans, MESH: Infant, MESH: Male, 3. Good health, MESH: Young Adult, MESH: Europe, MESH: Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/19231160
https://repub.eur.nl/pub/18031/
https://researchonline.lshtm.ac.uk/122228/
https://moh-it.pure.elsevier.com/en/publications/survival-of-european-children-and-young-adults-with-cancer-diagno
https://pubmed.ncbi.nlm.nih.gov/19231160/
https://digitalscholarship.unlv.edu/community_health_sciences_fac_articles/130/
http://www.journals.elsevier.com/european-journal-of-cancer/
https://doi.org/10.1016/j.ejca.2008.11.042
https://hdl.handle.net/11392/2380618
https://hdl.handle.net/11567/224596
https://doi.org/10.1016/j.ejca.2008.11.042
https://hdl.handle.net/11391/102355

Cancer‐specific and non‐cancer‐related mortality rates in European patients with T1a and T1b renal cell carcinoma

Authors: Zini, Laurent Patard, Jean-Jacques Capitanio, Umberto et al.

Contributors: Zini, Laurent Patard, Jean-Jacques Capitanio, Umberto et al.

Source: BJU International. 103:894-898

Subject Terms: MESH: Carcinoma, Male, [SDV.CAN]Life Sciences [q-bio]/Cancer, MESH: Epidemiologic Methods, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, Nephrectomy, prognostic factors, renal cell carcinoma, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, MESH: Risk Factors, Risk Factors, Humans, Carcinoma, Renal Cell, MESH: Treatment Outcome, Aged, MESH: Aged, MESH: Humans, MESH: Middle Aged, Renal Cell, Middle Aged, [SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, MESH: Male, Kidney Neoplasms, 3. Good health, MESH: Nephrectomy, Europe, MESH: Glomerular Filtration Rate, Treatment Outcome, Female, MESH: Europe, MESH: Kidney Neoplasms, Epidemiologic Methods, MESH: Female, Glomerular Filtration Rate

Access URL: https://pubmed.ncbi.nlm.nih.gov/19076131
https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1111/j.1464-410X.2008.08252.x
https://moh-it.pure.elsevier.com/en/publications/cancer-specific-and-non-cancer-related-mortality-rates-in-europea
http://www.ncbi.nlm.nih.gov/pubmed/19076131
https://pubmed.ncbi.nlm.nih.gov/19076131/
https://www.hal.inserm.fr/inserm-00354605
https://onlinelibrary.wiley.com/doi/full/10.1111/j.1464-410X.2008.08252.x
https://hdl.handle.net/20.500.11768/13621
https://doi.org/10.1111/j.1464-410X.2008.08252.x
https://hdl.handle.net/11577/2510714
https://doi.org/10.1111/j.1464-410X.2008.08252.x

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study

Authors: Bensimon, Gilbert Ludolph, Albert Agid, Yves et al.

Contributors: Bensimon, Gilbert Ludolph, Albert Agid, Yves et al.

Source: Brain

Subject Terms: Male, MESH: Multiple System Atrophy, Secondary, Psychometrics, Natural history, MESH: Epidemiologic Methods, Severity of Illness Index, MESH: Prognosis, 03 medical and health sciences, MESH: Riluzole, 0302 clinical medicine, MESH: Psychometrics, Progressive, MESH: Severity of Illness Index, Humans, Parkinson Disease, Secondary, MESH: Treatment Outcome, Aged, MESH: Aged, MESH: Humans, MESH: Middle Aged, Riluzole, MESH: Supranuclear Palsy, Progressive supranuclear palsy, MESH: Neuroprotective Agents, Multiple system atrophy, Original Articles, Middle Aged, Multiple System Atrophy, Prognosis, MESH: Male, 3. Good health, Neuroprotective Agents, Treatment Outcome, Randomized controlled trial, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Disease Progression, MESH: Disease Progression, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Supranuclear Palsy, Progressive, Epidemiologic Methods, MESH: Female, MESH: Parkinson Disease

File Description: application/pdf

Access URL: https://academic.oup.com/brain/article-pdf/132/1/156/16695185/awn291.pdf
https://pubmed.ncbi.nlm.nih.gov/19029129
https://www.ncbi.nlm.nih.gov/pubmed/19029129
https://www.ncbi.nlm.nih.gov/pmc/articles/2638696/
http://brain.oxfordjournals.org/content/132/1/156
https://academic.oup.com/brain/article/132/1/156/288009
http://europepmc.org/articles/PMC2638696
https://core.ac.uk/display/80062703
http://hdl.handle.net/11858/00-001M-0000-0011-2D5C-4
http://hdl.handle.net/21.11116/0000-000D-7806-6

Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia

Authors: Brethon, Benoit Yakouben, Karima Oudot, Caroline et al.

Contributors: Brethon, Benoit Yakouben, Karima Oudot, Caroline et al.

Source: British Journal of Haematology. 143:541-547

Subject Terms: Myeloid, [SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, Male, 0301 basic medicine, MESH: Epidemiologic Methods, 0302 clinical medicine, Recurrence, MESH: Child, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, MESH: Cytarabine, Child, Humanized, MESH: Treatment Outcome, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Cytarabine, Antibodies, Monoclonal, MESH: Aminoglycosides, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, MESH: Infant, Gemtuzumab, 3. Good health, MESH: Antineoplastic Combined Chemotherapy Protocols, Leukemia, Myeloid, Acute, Treatment Outcome, Child, Preschool, Female, Adolescent, [SDV.CAN]Life Sciences [q-bio]/Cancer, Acute, MESH: Drug Administration Schedule, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, MESH: Leukemia, Humans, Preschool, MESH: Drug Evaluation, MESH: Adolescent, MESH: Humans, MESH: Antibodies, Infant, MESH: Male, MESH: Recurrence, Aminoglycosides, Drug Evaluation, Epidemiologic Methods, MESH: Female, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology

Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2008.07370.x
https://pubmed.ncbi.nlm.nih.gov/18759760
https://hal-unilim.archives-ouvertes.fr/hal-00738025
http://europepmc.org/abstract/MED/18759760
https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2141.2008.07370.x
https://unilim.hal.science/hal-00738025v1
https://doi.org/10.1111/j.1365-2141.2008.07370.x

Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study

Authors: Cadranel, Jean-François Di Martino, Vincent Lambrey, Guy et al.

Contributors: Cadranel, Jean-François Di Martino, Vincent Lambrey, Guy et al.

Source: European Journal of Gastroenterology & Hepatology. 20:829-836

Subject Terms: Adult, Male, 0301 basic medicine, MESH: Diabetes Mellitus, MESH: Blood Transfusion, MESH: Hospitalization, MESH: Epidemiologic Methods, 03 medical and health sciences, 0302 clinical medicine, Diabetes Mellitus, Humans, Substance Abuse, Intravenous, Aged, MESH: Aged, Cross Infection, MESH: Humans, MESH: Middle Aged, MESH: Hepatitis B, MESH: Substance Abuse, MESH: Cross Infection, Transfusion Reaction, MESH: Adult, [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, Hepatitis C Antibodies, Middle Aged, Hepatitis B, MESH: Male, [SDV.MHEP.HEG] Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology, 3. Good health, MESH: France, Hospitalization, MESH: Hepatitis C Antibodies, Female, France, Intravenous, Epidemiologic Methods, MESH: Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/18794595
https://hal.archives-ouvertes.fr/hal-00465316
https://www.ncbi.nlm.nih.gov/pubmed/18794595
https://hal.science/hal-00465316v1
https://doi.org/10.1097/meg.0b013e3282fc73a1

Serological prevalence of echinococcosis and risk factors for infection among children in rural communities of southern Ningxia, China

Authors: Yang, Yu Rong Craig, Philip S Vuitton, Dominique A et al.

Contributors: Yang, Yu Rong Craig, Philip S Vuitton, Dominique A et al.

Source: Tropical Medicine & International Health. 13:1086-1094

Subject Terms: EmP antigen, 0301 basic medicine, MESH: Socioeconomic Factors, China, Adolescent, [SDE.MCG]Environmental Sciences/Global Changes, 920109 Infectious Diseases, Rural Health, MESH: Epidemiologic Methods, MESH: Echinococcus granulosus, children seroprevalence, MESH: Echinococcosis, 03 medical and health sciences, C1, 0302 clinical medicine, EgB antigen, MESH: Risk Factors, Echinococcosis, Risk Factors, MESH: Child, Animals, Humans, MESH: Animals, Child, MESH: Adolescent, MESH: Echinococcus multilocularis, Family Health, risk factors for infection, Ningxia Hui Autonomous Region, MESH: Humans, 110803 Medical Parasitology, Echinococcus granulosus, human alveolar and cystic echinococcosis, MESH: Rural Health, MESH: China, 3. Good health, Socioeconomic Factors, MESH: Family Health, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Echinococcus multilocularis, Epidemiologic Methods, filter-paper enzyme-linked immunosorbent assay

Access URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-3156.2008.02101.x
https://pubmed.ncbi.nlm.nih.gov/18554249
https://hal.archives-ouvertes.fr/hal-00342113
https://pubmed.ncbi.nlm.nih.gov/18554249/
https://www.ncbi.nlm.nih.gov/pubmed/18554249
https://espace.library.uq.edu.au/view/UQ:172816
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-3156.2008.02101.x